UNIVERSITY OF ARIZONA
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1885-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.arizona.edu
A Grapefruit Feeding Trial in Healthy, Overweight Adults
Not Applicable
Completed
- Conditions
- ObesityCardiovascular Risk FactorsWeight Loss
- Interventions
- Other: GrapefruitOther: Control
- First Posted Date
- 2011-10-17
- Last Posted Date
- 2011-10-17
- Lead Sponsor
- University of Arizona
- Target Recruit Count
- 85
- Registration Number
- NCT01452841
- Locations
- 🇺🇸
University of Arizona, Tucson, Arizona, United States
Electrophysiological Recording for Patients Receiving Deep Brain Stimulation Electrode for Treatment-resistant Obsessive-compulsive Disorder
Completed
- Conditions
- Obsessive-compulsive Disorder
- First Posted Date
- 2011-09-07
- Last Posted Date
- 2013-04-24
- Lead Sponsor
- University of Arizona
- Target Recruit Count
- 2
- Registration Number
- NCT01429558
- Locations
- 🇺🇸
University of Arizona, Tucson, Arizona, United States
Alzheimer's Disease Core Center
Recruiting
- Conditions
- Alzheimer's DiseaseMild Cognitive ImpairmentAge-Related Memory Disorders
- First Posted Date
- 2011-08-22
- Last Posted Date
- 2015-06-12
- Lead Sponsor
- University of Arizona
- Target Recruit Count
- 900
- Registration Number
- NCT01421420
- Locations
- 🇺🇸
University of Arizona, University Medical Center, Tucson, Arizona, United States
Neo-adjuvant Therapy With Anastrozole Plus Pazopanib in Stage II and III ER+ Breast Cancer
Phase 2
Terminated
- Conditions
- Estrogen Receptor-positive Breast CancerStage IIIA Breast CancerStage IIIB Breast CancerHuman Epidermal Growth Factor 2 Negative Carcinoma of BreastMale Breast CancerRecurrent Breast CancerStage II Breast Cancer
- Interventions
- First Posted Date
- 2011-07-14
- Last Posted Date
- 2018-07-26
- Lead Sponsor
- University of Arizona
- Target Recruit Count
- 2
- Registration Number
- NCT01394211
- Locations
- 🇺🇸
Arizona Cancer Center, Tucson, Arizona, United States
Diindolylmethane in Treating Patients With Breast Cancer
Not Applicable
Completed
- Conditions
- Stage IA Breast CancerStage IB Breast CancerStage II Breast CancerStage IIIA Breast Cancer
- Interventions
- Dietary Supplement: diindolylmethaneDietary Supplement: placebo
- First Posted Date
- 2011-07-12
- Last Posted Date
- 2017-11-06
- Lead Sponsor
- University of Arizona
- Target Recruit Count
- 144
- Registration Number
- NCT01391689
- Locations
- 🇺🇸
Arizona Cancer Center, Tucson, Arizona, United States
Pilot Study Estradiol Followed by Exemestane Hormone Receptor + Metastatic Breast Cancer
Not Applicable
Completed
- Conditions
- Estrogen Receptor-positive Breast CancerProgesterone Receptor Positive TumorRecurrent Breast CancerStage IIIC Breast CancerStage IV Breast Cancer
- Interventions
- Biological: therapeutic estradiolOther: laboratory biomarker analysisOther: enzyme-linked immunosorbent assay
- First Posted Date
- 2011-06-30
- Last Posted Date
- 2018-10-17
- Lead Sponsor
- University of Arizona
- Target Recruit Count
- 13
- Registration Number
- NCT01385280
- Locations
- 🇺🇸
University of Arizona Cancer Center, Tucson, Arizona, United States
Epidemiologic Follow Up Study of Newly Diagnosed Epilepsy Among Seniors
Completed
- Conditions
- Epileptic Seizures
- First Posted Date
- 2011-05-11
- Last Posted Date
- 2017-11-06
- Lead Sponsor
- University of Arizona
- Target Recruit Count
- 97
- Registration Number
- NCT01351727
- Locations
- 🇺🇸
Pima, Cochise, Santa Cruz Counties, Tucson, Arizona, United States
The EPIC Project: Impact of Implementing the EMS Traumatic Brain Injury Treatment Guidelines
Completed
- Conditions
- Injuries, Acute BrainTBI (Traumatic Brain Injury)Brain Injuries, Traumatic
- Interventions
- Other: The National Prehospital TBI Management Guidelines
- First Posted Date
- 2011-04-21
- Last Posted Date
- 2018-08-28
- Lead Sponsor
- University of Arizona
- Target Recruit Count
- 26873
- Registration Number
- NCT01339702
- Locations
- 🇺🇸
Arizona Emergency Medicine Research Center, Phoenix, Arizona, United States
Emergency Treatment of Coral Snake Envenomation With Antivenom
Phase 3
Completed
- Conditions
- Coral Snake BiteToxic Effect of Coral Snake Venom
- Interventions
- Drug: Snake (Micrurus) North American immune F(ab')2 Equine
- First Posted Date
- 2011-04-18
- Last Posted Date
- 2023-05-26
- Lead Sponsor
- University of Arizona
- Target Recruit Count
- 26
- Registration Number
- NCT01337245
- Locations
- 🇺🇸
Florida Hospital Deland, DeLand, Florida, United States
🇺🇸St. Lucie Medical Center, Port Saint Lucie, Florida, United States
🇺🇸Banner University Medical Center, Tucson, Arizona, United States
Paclitaxel and Bavituximab in Treating Patients With HER2-Negative Metastatic Breast Cancer
Phase 1
Completed
- Conditions
- Stage IIIC Breast CancerStage IV Breast CancerMale Breast CancerHuman Epidermal Growth Factor 2 Negative Carcinoma of BreastRecurrent Breast Cancer
- Interventions
- Biological: bavituximabOther: laboratory biomarker analysisOther: pharmacological study
- First Posted Date
- 2011-02-02
- Last Posted Date
- 2016-04-21
- Lead Sponsor
- University of Arizona
- Target Recruit Count
- 14
- Registration Number
- NCT01288261
- Locations
- 🇺🇸
Arizona Cancer Center, Tucson, Arizona, United States
© Copyright 2025. All Rights Reserved by MedPath